GLENDALE, Calif., June 16, 2015 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated patient-centered, physician-driven healthcare delivery company, today announced that its network of physicians has surpassed 1000 providers and that its population health management business covers over 40,000 patients.
Through its capitated, at-risk entity, Maverick Medical Group, and its accountable care organization, ApolloMed ACO, ApolloMed is providing leading population health management services for over 40,000 of its own patients. The Company's integrated care platform and technology-enabled outcomes have resulted in superior clinical, financial and patient satisfaction metrics, meeting the Institute of Healthcare Improvement's and CMS goals of the Triple Aim: Improving the patient experience of care (including quality and patient satisfaction), improving the health of populations and reducing the per capita cost of health care. ApolloMed developed its network of medical group and ACO physicians in just three years, beginning in 2012. A larger network leads to more patients under medical management, which translates into higher revenues for the Company.
In addition to providing care for its own patients, ApolloMed provides leading care to over 75,000 additional patients for its clients, including health plans, hospitals and other medical groups, through its network of dedicated hospitalists, nursing home physicians, clinic physicians and extenders, hospice/palliative care group and home health agency. ApolloMed provides care for some of the most complex and highest cost patients in the U.S. healthcare system.
"Over the past three years, we have built a growing, robust network of physicians and an outcome-centric population health management platform that is at the forefront of the movement to value-based care," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. "The federal government earlier this year set a goal of tying 50% of traditional, fee-for-service Medicare payments through alternative payment models, such as ACOs or bundled payment arrangements by the end of 2018, and also set a goal of tying 90% of all Medicare payments to quality or value by the end of 2018. We believe ApolloMed is well positioned to benefit from these transformative changes and sizeable market growth over the next decade."
About Apollo Medical Holdings, Inc.
Headquartered in Glendale, California, ApolloMed is a leading integrated patient-centered, physician-centric healthcare delivery company committed to providing exceptional multi-disciplinary care in the communities it serves. ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated healthcare delivery platform comprised of six affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association), AKM Medical Group (IPA), ApolloMed Care Clinics and Apollo Palliative Services. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, please visit www.apollomed.net
Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. ("the Company"). In particular, when used in the preceding discussion, the words "predicts," "believes," "expects," "intends," "seeks," "estimates," "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as "will," "may," "might," "should," "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company's management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. The Company has submitted an initial listing application to the Nasdaq Stock Market to have its common stock approved for listing on the Nasdaq Capital Market. At present, the Company does not meet all of the initial listing requirements of the Nasdaq Capital Market and therefore the Company cannot assure that the listing will be approved. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended January 31, 2014 and in any of the Company's other subsequent Securities and Exchange Commission filings.
FOR ADDITIONAL INFORMATION
800-733-2447 Ext. 115 or via email at [email protected]
SOURCE Apollo Medical Holdings, Inc.